Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Gross Profit (2025)

Coeptis Therapeutics Holdings has reported Gross Profit over the past 1 years, most recently at $816892.0 for Q4 2025.

  • Quarterly results put Gross Profit at $816892.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $1.2 million (changed N/A YoY), and the annual figure for FY2025 was $1.2 million, changed.
  • Gross Profit for Q4 2025 was $816892.0 at Coeptis Therapeutics Holdings, up from $192286.0 in the prior quarter.
  • Over the last five years, Gross Profit for COEPW hit a ceiling of $816892.0 in Q4 2025 and a floor of $17718.0 in Q1 2025.